Tremfya hits endpoints in psoriatic arthritis study

12th November 2019 Uncategorised 0

24-week data from the clinical trial showed at least a 20% improvement in disease signs and symptoms compared to placebo.

More: Tremfya hits endpoints in psoriatic arthritis study
Source: News